Advancements in artificial intelligence for the precise diagnosis and treatment of hematological malignancies
10.3760/cma.j.cn121090-20241022-00409
- VernacularTitle:人工智能在血液肿瘤精准诊疗中的应用进展
- Author:
Haoxu YANG
1
;
Jie XIONG
1
;
Weili ZHAO
1
Author Information
1. 上海交通大学医学院附属瑞金医院血液科，医学基因组学国家重点实验室，上海血液学研究所，上海 200025
- Publication Type:Journal Article
- From:
Chinese Journal of Hematology
2025;46(2):186-192
- CountryChina
- Language:Chinese
-
Abstract:
Hematological malignancy is a highly heterogeneous disease with complex biological characteristics and diverse clinical manifestations. Therefore, precise diagnosis and treatment are crucial and urgently needed. To further improve the accuracy of diagnosis and prognostication and to promote personalized therapy, artificial intelligence (AI) has been increasingly used. This study reviewed literature published in the last 5 years and summarized the application, benefits, and drawbacks of AI in the diagnosis, treatment, and prognosis of hematologic malignancies. Although AI can effectively improve the accuracy of diagnosis and therapy, low-quality data, poor interpretability of the model, and limited clinical transformation have impeded its popularization and application. In the future, the clinical application of AI in hematologic malignancy can be accelerated by establishing standards for clinical data processing, integrating multimodal information for accurate diagnosis and prognostication, and conducting systematic clinical verification of model algorithms.
